Literature DB >> 8845090

Compliance in the treatment of hypertension. A need for action.

R W Sanson-Fisher1, K Clover.   

Abstract

Compliance is commonly defined as the extent to which a person's behavior coincides with medical or health advice. There is evidence that noncompliance is a common problem with many medications, including antihypertensive treatment. Since noncompliance can have serious adverse effects on patient health it is important that practitioners make use of available strategies for increasing compliance. This paper considers aspects of the literature concerning noncompliance with antihypertensive medications and presents a number of strategies that practitioners can use to increase compliance. These include strategies for increasing patient recall of information and for implementing reminder systems. There is some evidence that eliciting social support can aid compliance as can presenting information about side effects. The importance of prescribing the simplest possible dosage regimen is emphasized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845090     DOI: 10.1016/0895-7061(95)00195-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  9 in total

1.  Compliance and hypertension.

Authors:  F B Garfield; J J Caro
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

2.  Brief provider communication skills training fails to impact patient hypertension outcomes.

Authors:  Meredith G Manze; Michelle B Orner; Mark Glickman; Lori Pbert; Dan Berlowitz; Nancy R Kressin
Journal:  Patient Educ Couns       Date:  2014-10-27

Review 3.  Sexual dysfunction in patients with hypertension: implications for therapy.

Authors:  Carlos M Ferrario; Pavel Levy
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

4.  Clinical outcomes and healthcare costs in hypertensive patients treated with a fixed-dose combination of amlodipine/valsartan.

Authors:  Ying-Chang Tung; Yu-Sheng Lin; Lung-Sheng Wu; Chee-Jen Chang; Pao-Hsien Chu
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-12-05       Impact factor: 3.738

5.  The differential impact of subjective and objective aspects of social engagement on cardiovascular risk factors.

Authors:  Yumiko Kamiya; Brendan Whelan; Virpi Timonen; Rose Anne Kenny
Journal:  BMC Geriatr       Date:  2010-11-02       Impact factor: 3.921

6.  [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].

Authors:  Hind El Aassri; Ghizlane El Mghari; Nawal El Ansari
Journal:  Pan Afr Med J       Date:  2014-03-13

7.  Nonadherence to Antihypertensive Medication Among Hypertensive Adults in the United States─HealthStyles, 2010.

Authors:  Xin Tong; Elizabeth K Chu; Jing Fang; Hilary K Wall; Carma Ayala
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-03       Impact factor: 3.738

Review 8.  Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide.

Authors:  J M Flack
Journal:  Int J Clin Pract       Date:  2007-09-20       Impact factor: 2.503

9.  Predictors of Noncompliance to Antihypertensive Therapy among Hypertensive Patients Ghana: Application of Health Belief Model.

Authors:  Yaa Obirikorang; Christian Obirikorang; Emmanuel Acheampong; Enoch Odame Anto; Daniel Gyamfi; Selorm Philip Segbefia; Michael Opoku Boateng; Dari Pascal Dapilla; Peter Kojo Brenya; Bright Amankwaa; Evans Asamoah Adu; Emmanuel Nsenbah Batu; Adjei Gyimah Akwasi; Beatrice Amoah
Journal:  Int J Hypertens       Date:  2018-06-19       Impact factor: 2.420

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.